Early Stage Venture Dren Bio Raises Series A of $60000000

October 15, 2020

About Dren Bio

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Website: Learn more on Dren Bio’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Dren Bio

Amount Raised60000000 USD
Announced Date2020-10-16
Equity Only FundingYes
Organization LocationFoster City, California, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead InvestorsSR One, Taiho Ventures
Number of Investors7
Number of Partner Investors2